Stan rekrutacji pochodzi z rejestrów badań i może się zmienić szybciej, niż zaktualizuje go sponsor. Nasz doradca sprawdzi aktualny stan w wybranym ośrodku. Nie publikujemy nazwisk lekarzy ani ich danych kontaktowych.
Cel badania
Opis z rejestru (w języku angielskim):
This clinical trial is a prospective, multicenter, open label study designed to evaluate the effectiveness and the safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection in patients eligible for thoracic endovascular aortic repair with stent grafts.
Leczenie w badaniu
Lek / interwencja
Rola
Postać, podanie
Allay Aortic Stent
Wyrób medyczny
Kryteria udziału
Kryteria w języku angielskim, tak jak w rejestrze.
Kryteria włączenia kto może wziąć udział (3)
Have a type B aortic dissection extending to the celiac trunk or beyond
Are eligible for thoracic endovascular treatment with stent grafts as per local guidelines, and physician's decision
Have been elected for treatment with commercially available stent graft as per their IFU within 90 days of dissection symptoms onset
Kryteria wyłączenia kto nie może wziąć udziału (30)
General Exclusion Criteria:
Age < 18 years
Pregnant, breast-feeding or planning on becoming pregnant during the entire duration of the study
Unable to provide written informed consent
Unable or unwilling to comply with the requirements of the study protocol
Taking part already in an investigational device or drug study that could interfere with the outcomes being studied
Active drug addiction or known history of drug abuse within one year of treatment
Medical Exclusion Criteria:
Aortic rupture (free or contained including haemothorax, increasing periaortic hematoma, or mediastinal hematoma)
Aortic fistula
Suspicion of bowel necrosis or irreversible visceral ischemia
Stage 5 chronic kidney disease
Life expectancy of less than 2 years due to any other medical condition than the dissection to be treated
Active malignancy
Known sensitivities or allergies to the device materials (including cobalt, chromium, nickel)
Known sensitivities or allergies to contrast materials that cannot be pre-medicated
Mycotic aortic aneurysm or active systemic infection that may place the patient at increased risk of endovascular infection
American Society of Anaesthesiologists (ASA) class V (moribund patient not expected to live 24 hours with or without operation)
Diagnosed or suspected congenital degenerative connective tissue disease (e.g., Marfan's, Loeys-Dietz or Ehlers-Danlos syndrome)
Uncorrectable coagulopathy, bleeding diathesis or refusal of blood transfusion
Any major cardiovascular or cerebrovascular ischemic event, including myocardial infarction or stroke, or treatment of such event, within 90 days prior to enrolment
Any aortic-related interventional or surgical procedure within 30 days prior to enrolment
Any planned aortic-related interventional or surgical procedure within 30 days after the study procedure
Anatomical Exclusion Criteria:
Aneurysmal dilatation of the false lumen defined as maximum transaortic diameter >55 mm in women or >60 mm in men in the thoraco-abdominal segment or >50 mm in women or >55 mm in men in the abdominal segment, measured inner-wall to inner-wall;
Inadequate proximal landing zone for the stent graft, such zone being <20 mm long
Inadequate proximal landing zone geometry for the Allay® Aortic Stent (e.g. aortic kink)
Planned implantation of a stent graft with a distal diameter >38 mm or <20 mm
Aorta or iliac anatomy not allowing the advancement of the delivery system
Subject in whom the thoracic stent graft is either 1) not implanted in its intended position and/or 2) leads to any serious device complication, and/or who has 3) persistent static obstruction of the visceral or both renal arteries, prior to Allay® Aortic Stent implantation, will not be implanted with the Allay® Aortic Stent and will be withdrawn from the study
To główne kryteria z rejestru. Pełną listę i ostateczną decyzję o udziale ustala lekarz prowadzący badanie.
Zapytaj o udział w tym badaniu
Zadzwoń, a nasz doradca ds. badań sprawdzi z Tobą wstępnie kryteria i pomoże skontaktować się z ośrodkiem. Kwalifikację zawsze przeprowadza lekarz w ośrodku. Udział w badaniu jest bezpłatny i dobrowolny.
Evaluation of the Efficacy of Valsartan in Slowing Down Aortic Root Dilatation in Children and Young Adults with Marfan-type Heritable Thoracic Aortic Diseases – Valsar-TAD, a…
Badane leki:valsartan
Miasta: Gdańsk, Kraków, Warszawa, ŁódźWiek: do 64 latSponsor: Medical University Of Gdansk
Informacje pochodzą z publicznych rejestrów badań klinicznych (CTIS - Unia Europejska, ClinicalTrials.gov - USA) i są aktualizowane codziennie. Mogą różnić się od aktualnego stanu w ośrodku. Ostateczną kwalifikację do badania zawsze przeprowadza lekarz w ośrodku badawczym. Stan na 10 listopada 2026.